Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Are we going to see further information?

Can we review the amended ComAg agreement? Or will that just show we caved in negotiations? Otherwise what has changed between Leckrone and our management?

Shareholders can't be expected to be patient. 5 years since the run up is long enough. So now PTSC supposedly has more freedom to communicate to shareholders. PTSC can start with publicizing the new ComAg that must finally be balanced.

GLTAL

Share
New Message
Please login to post a reply